| Part 1. Chair: Anders Rosendal Korshøj. |
09:15 | A platform for treatment of rare diseases | Søren Lykke-Andersen, Department of Molecular Biology and Genetics, AU |
09:30 | New method to estimate correct serum lithium levels | Ole Köhler-Forsberg, Department of Clinical Medicine, AU |
09:45 | Allosteric transglutaminase 2 modulations to treat chronic kidney disease | Estéfano Pinilla, Department of Biomedicine, AU |
10:00 | Creating a stem cell therapy for Parkinson's disease | Mark Denham, Department of Biomedicine, AU |
10:15 | APTASHAPE, an unbiased biomarker discovery technology, using highly parallelized RNA aptamer screens, applied to cancer, neuro- and cardiovascular diseases | Jørgen Kjems, Department of Molecular Biology and Genetics, iNANO, AU |
| 10:30 | Individual networking |
| Part 2. Chairs: Karin Lykke-Hartmann, Michael Pedersen. |
| 13:00 | Gene therapy of AML | Christian Kanstrup Holm, Department of Biomedicine, AU |
| 13:15 | Unlocking the diagnostic value of urinary acid/base biomarkers | Jens Georg Leipziger, Department of Biomedicine, AU |
| 13:30 | Capture and culture of circulating tumor cells: Towards a new cancer treatment paradigm | Sara Seidelin Majidi, Department of Biological and Chemical Engineering, AU |
| 13:45 | Allergen traps for seasonal protection against anaphylaxis | Edzard Spilner, Department of Biological and Chemical Engineering, AU |
| 14:00 | Early identification of clinical deterioration among hospitalized patients by explainable AI | Ulrik Skipper Espelund, Department of Clinical Medicine, AU/Horsens Hospital, Central Denmark Region. |
| 14:15 | Individual networking of presenters and panel members |
